back to cluster viewer
cluster path 110100111100
50 words, 131,959 tokens
freq alpha suffix
Words in frequency order
1 | using | 128,891
|
2 | utilizing | 1,602
|
3 | employing | 1,183
|
4 | utilising | 232
|
5 | blood-normalized | 3
|
6 | deconvoluting | 2
|
7 | hplc-esi-ms. | 2
|
8 | reverse-transcribed | 2
|
9 | 111in-octreotide | 1
|
10 | 19,854 | 1
|
11 | 2,7-diphenyl | 1
|
12 | 2.27+/-0.61 | 1
|
13 | 237,221 | 1
|
14 | 38,436 | 1
|
15 | 39,515 | 1
|
16 | 478,864 | 1
|
17 | 5-ala-induced | 1
|
18 | 55.8±32.8 | 1
|
19 | 6430 | 1
|
20 | ad/ipd | 1
|
21 | bymice | 1
|
22 | cao-sio2-b2o3 | 1
|
23 | carraguard® | 1
|
24 | chlamydia/gonorrhoea | 1
|
25 | chr6q25.3 | 1
|
26 | diffrent | 1
|
27 | disorder-assisted | 1
|
28 | dual-labeled | 1
|
29 | end-term | 1
|
30 | gii.p16 | 1
|
31 | gm1ganglioside | 1
|
32 | hepatocytes.our | 1
|
33 | his6-tagged | 1
|
34 | htl-mediated | 1
|
35 | ibm® | 1
|
36 | igf-i/sm-c | 1
|
37 | irradiation/reading | 1
|
38 | measures-six-minute | 1
|
39 | medicare-linked | 1
|
40 | models-64-slice | 1
|
41 | multicollector | 1
|
42 | outcomesthe | 1
|
43 | people-particularly | 1
|
44 | previously.in | 1
|
45 | reward-dependent | 1
|
46 | silac-based | 1
|
47 | single-distribution | 1
|
48 | usin | 1
|
49 | valence-band | 1
|
50 | world.as | 1
|
Words in alphabetical order
1 | 111in-octreotide | 1
|
2 | 19,854 | 1
|
3 | 2,7-diphenyl | 1
|
4 | 2.27+/-0.61 | 1
|
5 | 237,221 | 1
|
6 | 38,436 | 1
|
7 | 39,515 | 1
|
8 | 478,864 | 1
|
9 | 5-ala-induced | 1
|
10 | 55.8±32.8 | 1
|
11 | 6430 | 1
|
12 | ad/ipd | 1
|
13 | blood-normalized | 3
|
14 | bymice | 1
|
15 | cao-sio2-b2o3 | 1
|
16 | carraguard® | 1
|
17 | chlamydia/gonorrhoea | 1
|
18 | chr6q25.3 | 1
|
19 | deconvoluting | 2
|
20 | diffrent | 1
|
21 | disorder-assisted | 1
|
22 | dual-labeled | 1
|
23 | employing | 1,183
|
24 | end-term | 1
|
25 | gii.p16 | 1
|
26 | gm1ganglioside | 1
|
27 | hepatocytes.our | 1
|
28 | his6-tagged | 1
|
29 | hplc-esi-ms. | 2
|
30 | htl-mediated | 1
|
31 | ibm® | 1
|
32 | igf-i/sm-c | 1
|
33 | irradiation/reading | 1
|
34 | measures-six-minute | 1
|
35 | medicare-linked | 1
|
36 | models-64-slice | 1
|
37 | multicollector | 1
|
38 | outcomesthe | 1
|
39 | people-particularly | 1
|
40 | previously.in | 1
|
41 | reverse-transcribed | 2
|
42 | reward-dependent | 1
|
43 | silac-based | 1
|
44 | single-distribution | 1
|
45 | usin | 1
|
46 | using | 128,891
|
47 | utilising | 232
|
48 | utilizing | 1,602
|
49 | valence-band | 1
|
50 | world.as | 1
|
Words in suffix order
1 | hplc-esi-ms. | 2
|
2 | 6430 | 1
|
3 | 237,221 | 1
|
4 | 2.27+/-0.61 | 1
|
5 | chr6q25.3 | 1
|
6 | cao-sio2-b2o3 | 1
|
7 | 19,854 | 1
|
8 | 478,864 | 1
|
9 | 39,515 | 1
|
10 | gii.p16 | 1
|
11 | 38,436 | 1
|
12 | 55.8±32.8 | 1
|
13 | chlamydia/gonorrhoea | 1
|
14 | igf-i/sm-c | 1
|
15 | reverse-transcribed | 2
|
16 | 5-ala-induced | 1
|
17 | his6-tagged | 1
|
18 | medicare-linked | 1
|
19 | dual-labeled | 1
|
20 | silac-based | 1
|
21 | htl-mediated | 1
|
22 | disorder-assisted | 1
|
23 | blood-normalized | 3
|
24 | valence-band | 1
|
25 | ad/ipd | 1
|
26 | models-64-slice | 1
|
27 | bymice | 1
|
28 | gm1ganglioside | 1
|
29 | 111in-octreotide | 1
|
30 | outcomesthe | 1
|
31 | measures-six-minute | 1
|
32 | irradiation/reading | 1
|
33 | utilising | 232
|
34 | using | 128,891
|
35 | deconvoluting | 2
|
36 | employing | 1,183
|
37 | utilizing | 1,602
|
38 | 2,7-diphenyl | 1
|
39 | end-term | 1
|
40 | previously.in | 1
|
41 | usin | 1
|
42 | single-distribution | 1
|
43 | multicollector | 1
|
44 | hepatocytes.our | 1
|
45 | world.as | 1
|
46 | reward-dependent | 1
|
47 | diffrent | 1
|
48 | people-particularly | 1
|
49 | carraguard® | 1
|
50 | ibm® | 1
|